This review first describes the mechanisms underlying tumor escape mediated by PD-1/PD-L1 and briefly summarizes the limitations and effectiveness of anti-PD-1/PD-L1 mAbs and the need to develop small molecule drugs. Here, CD274 is linked to neoplasm.